PCV2 Comparative Efficacy and Safety Analysis of Atrial Fibrillaion Patients Treated with Dabigatran in RE-LY Study (CHADS 2 Score of 3 or Greater ) Versus Rivaroxaban in ROCKET-AF
2018 ◽
Vol 11
(5)
◽
pp. 691-697
Keyword(s):
2020 ◽
Keyword(s):
2019 ◽
Vol 12
(1)
◽
pp. 48-54
Keyword(s):
Keyword(s):
Keyword(s):